ArticleNutrients2023

Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor.

Jia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.